BIOLIFE SOLUTIONS INC 8-K

What Happened

• On January 12, 2026, BioLife Solutions, Inc. announced preliminary unaudited revenue for the fourth quarter and the full year ended December 31, 2025 via a press release. The company furnished that press release as Exhibit 99.1 to its Form 8-K filed the same day.

Key Details

• Item reported: 2.02 (Results of Operations and Financial Condition) — preliminary unaudited revenue for Q4 and FY2025.
• Press release furnished as Exhibit 99.1 to the Form 8-K (filed Jan 12, 2026).
• Form 8-K was signed by Troy Wichterman, Chief Financial Officer, on behalf of the company.
• The filing also includes the cover page interactive XBRL file (Exhibit 104).

Why It Matters

• This filing gives investors an early, unaudited view of BioLife’s revenue performance for Q4 and full-year 2025 ahead of final audited results (e.g., in the 10-K). Preliminary revenue figures can affect expectations for the company’s earnings and near-term outlook. Investors should review the furnished press release for the specific revenue figures and monitor subsequent filings for audited results and additional context.